Abcuro News and Activities

Acquisition, funding and merger involving Abcuro.

• Abcuro has just announced a $200 Million fundraising (posted on February 17 2025).

View the org chart displaying its 47 main executives

Most searched biographies at Abcuro

• Alex Martin, Chief Executive Officer
• Michele Park, Director
• Ming Fang, Director

Create your alert
to follow the executive moves at Abcuro.

Abcuro has 2,414 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).
• Boundless Bio will change its company name to Serapha Bio on Dec 31, 2026. (posted on June 23 2026).
• Osanni Bio has just announced a $190 Million fundraising (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Abcuro

• News - Abcuro
• Press Releases - Abcuro

Social media about Abcuro

• Abcuro on Wikipedia, Google News & Yahoo Finance
• Abcuro on LinkedIn, X (Twitter) & YouTube